Document detail

The objective of this report is to assess the situational landscape during mid-May 2020 surrounding the value chain of the production and distribution of generic antiretroviral medicines in low- and-middle-income countries and to provide recommendations on mitigating the risks of potential disruptions.

COVID-19,  ART,  access to art,  HIV,  treatment disruptions,  Antiretroviral therapy (ART),